Location History:
- Malden, MA (US) (2000 - 2001)
- Medford, MA (US) (2015)
Company Filing History:
1 out of 8,373 
2 out of 832,812 Years Active: 2000-2015
Title: Maria Ann Rupnick: Innovator in Cell-Protection and Vascular Regulation
Introduction
Maria Ann Rupnick is a distinguished inventor based in Medford, MA (US). She has made significant contributions to the field of biomedical research, particularly in the development of innovative peptides and methods for regulating tissue growth. With a total of 3 patents, her work has the potential to impact various medical conditions related to cell death and tissue regulation.
Latest Patents
One of her latest patents is focused on cell-protective peptides and their uses. This patent describes a peptide comprising the amino acid sequence XXRXDXXXX, which can be utilized in biomaterials aimed at treating conditions resulting from cell death or apoptosis. Another notable patent outlines a method for regulating the size of vascularized normal tissue. This method involves administering angiogenesis inhibitors to patients, effectively controlling the growth of various tissues, including adipose tissue, intestinal polyps, muscle tissue, and endometrial tissue. The findings indicate that the response of these tissues to the inhibitors is dose-dependent and reversible, showcasing the potential for significant therapeutic applications.
Career Highlights
Throughout her career, Maria has worked with prestigious institutions, including the Massachusetts Institute of Technology. Her research has been pivotal in understanding the mechanisms of angiogenesis and its implications for obesity, cardiac hypertrophy, and endometriosis.
Collaborations
Maria has collaborated with notable figures in the field, including Robert Samuel Langer and Judah M Folkman. Their combined expertise has contributed to advancing research in tissue engineering and regenerative medicine.
Conclusion
Maria Ann Rupnick's innovative work in cell protection and tissue regulation exemplifies the impact of scientific research on medical advancements. Her patents and collaborations highlight her commitment to improving health outcomes through innovative solutions.